Want to join the conversation?
$BIIB said Paul McKenzie replaces John Cox, who last month was named CEO of a new Biogen spin-off company dedicated to advancing treatments for hemophilia. McKenzie will also oversee construction and operation of $BIIB's advanced biologics manufacturing facility in Solothurn, Switzerland.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.